Eagle Health Investments LP: SCHOLAR ROCK HLDG CORP (SRRK): Quarterly 13F Position History
As of Q2 2026, Eagle Health Investments LP reported 555,272 shares of SCHOLAR ROCK HLDG CORP (SRRK), worth $30.5M and representing 5.1% of its 13F equity book. Quarter-over-quarter share count change: + 61,253 (+12.4%) . The position first appeared in Q2 2025 and has been disclosed across 5 13F-HR filings in Pactolio's tracked window.
- 555,272Shares Held (Latest Filing)
- $30.5MReported Market Value (Latest Filing)
- 5.1%Portfolio Weight (% of 13F Equity Book)
- +61,253Quarter-over-Quarter Share Change
- +$6.3MQuarter-over-Quarter Value Change
- 555,272Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 5 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 555,272 | +61,253 | +12.4% | $30.5M | 5.1% | $55.0 |
| Q1 2026 | 494,019 | +130,719 | +36.0% | $24.3M | 5.1% | $49.2 |
| Q4 2025 | 363,300 | 0 | – | $16.0M | 3.5% | $44.0 |
| Q3 2025 | 363,300 | +93,900 | +34.9% | $13.5M | 3.6% | $37.2 |
| Q2 2025 | 269,400 | – | – | $9.5M | 2.4% | $35.4 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Eagle Health Investments LP first disclose a SRRK position in 13F-HR filings?
Eagle Health Investments LP first reported SCHOLAR ROCK HLDG CORP (SRRK) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 5 reported quarters within Pactolio's tracked window.
What was Eagle Health Investments LP's most recent quarter-over-quarter share-count change in SRRK?
Between Q1 2026 and Q2 2026, Eagle Health Investments LP added 61,253 shares of SRRK (+12.4%), bringing the total reported position to 555,272 shares at a market value of $30.5M.
Does the implied price-per-share represent Eagle Health Investments LP's cost basis in SRRK?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.